Preliminary results of a phase II study using response-adapted therapy for limited-stage diffuse large B-cell lymphoma based on interim PET/CT

Hematological Oncology ◽

10.1002/hon.2439_34 ◽

2017 ◽

Vol 35 ◽

pp. 301-302

Author(s):

F. Lv ◽

Z. Xia ◽

K. Xue ◽

Q. Zhang ◽

D. Ji ◽

...

Keyword(s):

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Preliminary Results ◽

Interim Pet ◽

Large B Cell Lymphoma ◽

Pet Ct ◽

Download Full-text

Preliminary results of a phase II study of rituximab (R), gemcitabine (Gem), oxaliplatin (Ox) plus enzastaurin (ENZ) followed by ENZ maintenance as salvage regimen for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.8069 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 8069-8069 ◽

Author(s):

C. Haioun ◽

F. Morschhauser ◽

E. Jourdan ◽

J. Karsenti ◽

G. Hess ◽

...

Keyword(s):

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Salvage Regimen ◽

Preliminary Results ◽

Large B Cell Lymphoma ◽

Download Full-text

Response-adapted therapy for limited stage diffuse large B-cell lymphoma based on interim PET-CT: preliminary results of a phase 2 study

The Lancet Oncology ◽

10.1016/s1470-2045(17)30766-0 ◽

2017 ◽

Vol 18 ◽

pp. S10

Author(s):

Fangfang Lv ◽

Zuguang Xia ◽

Kai Xue ◽

Qunling Zhang ◽

Dongmei Ji ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Phase 2 ◽

Preliminary Results ◽

Interim Pet ◽

Large B Cell Lymphoma ◽

Pet Ct ◽

Phase 2 Study ◽

Download Full-text

Clinical Efficacy and Epigenetic Biomarkers in a Phase II Study of Chidamide Plus R-CHOP in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

SSRN Electronic Journal ◽

10.2139/ssrn.3532538 ◽

2020 ◽

Author(s):

Mu-Chen Zhang ◽

Peng-Peng Xu ◽

Ying Fang ◽

Li Wang ◽

Shu Cheng ◽

...

Keyword(s):

Elderly Patients ◽

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Newly Diagnosed ◽

Epigenetic Biomarkers ◽

Large B Cell Lymphoma ◽

Download Full-text

LONG‐TERM ANALYSES FROM L‐MIND, A PHASE II STUDY OF TAFASITAMAB PLUS LENALIDOMIDE (LEN) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (R/R DLBCL)

Hematological Oncology ◽

10.1002/hon.28_2879 ◽

2021 ◽

Vol 39 (S2) ◽

Author(s):

J Duell ◽

K. J Maddocks ◽

E González‐Barca ◽

W Jurczak ◽

A. M Liberati ◽

...

Keyword(s):

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

Download Full-text

Phase II Study of Bendamustine and Ofatumumab in Elderly Patients with Newly Diagnosed Diffuse Large B‐Cell Lymphoma Who Are Poor Candidates for R‐CHOP Chemotherapy

The Oncologist ◽

10.1634/theoncologist.2019-0286 ◽

2019 ◽

Vol 24 (8) ◽

pp. 1035 ◽

Author(s):

Ian W. Flinn ◽

Jack Erter ◽

Davey B. Daniel ◽

Joseph R. Mace ◽

Jesus G. Berdeja

Keyword(s):

Elderly Patients ◽

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Newly Diagnosed ◽

Chop Chemotherapy ◽

Large B Cell Lymphoma ◽

Download Full-text

Risk Stratification Of Diffuse Large B-Cell Lymphoma With Interim PET/CT By Combining Deauville Scores And International Prognostic Index

Cancer Management and Research ◽

10.2147/cmar.s218678 ◽

2019 ◽

Vol Volume 11 ◽

pp. 9449-9457

Author(s):

Hongwei Sun ◽

Zhan Yu ◽

Ning Ma ◽

Jie Zhou ◽

Rongrong Tian ◽

...

Keyword(s):

Risk Stratification ◽

B Cell ◽

Cell Lymphoma ◽

International Prognostic Index ◽

Prognostic Index ◽

B Cell Lymphoma ◽

Interim Pet ◽

Large B Cell Lymphoma ◽

Pet Ct ◽

Download Full-text

Interim PET/CT based on visual and semiquantitative analysis predicts survival in patients with diffuse large B‐cell lymphoma

Cancer Medicine ◽

10.1002/cam4.2404 ◽

2019 ◽

Vol 8 (11) ◽

pp. 5012-5022 ◽

Author(s):

Xiaoqian Li ◽

Xun Sun ◽

Juan Li ◽

Zijian Liu ◽

Mi Mi ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Semiquantitative Analysis ◽

Interim Pet ◽

Large B Cell Lymphoma ◽

Pet Ct ◽

Download Full-text

ARGO: A RANDOMISED PHASE II STUDY OF ATEZOLIZUMAB WITH RITUXIMAB, GEMCITABINE AND OXALIPLATIN IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA WHO ARE NOT CANDIDATES FOR HIGH-DOSE THERAPY

Hematological Oncology ◽

10.1002/hon.1_2632 ◽

2019 ◽

Vol 37 ◽

pp. 555-556

Author(s):

A.J. Davies ◽

O. Tansley Hancock ◽

T. Cummin ◽

J. Caddy ◽

L. Stanton ◽

...

Keyword(s):

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

High Dose ◽

High Dose Therapy ◽

Dose Therapy ◽

Large B Cell Lymphoma ◽

Download Full-text

Japanese multicenter phase II study of CHOP followed by radiotherapy (RT) in stage I-II1 diffuse large B-cell lymphoma (DLBCL) of the stomach

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.6527 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 6527-6527

Author(s):

S. Ishikura ◽

K. Tobinai ◽

A. Ohtsu ◽

S. Nakamura ◽

T. Yoshino ◽

...

Keyword(s):

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Stage I ◽

Large B Cell Lymphoma ◽

Multicenter Phase ◽

Download Full-text

A phase II study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy (ER-CHOP) in patients with previously untreated diffuse large B-cell lymphoma

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.8500 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 8500-8500 ◽

Author(s):

I. N. Micallef ◽

M. J. Maurer ◽

D. A. Nikcevich ◽

M. Cannon ◽

D. F. Moore ◽

...

Keyword(s):

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

Download Full-text